NO20041086L - Aminoindazolderivatrer aktive som kinaseinhibitorer, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som inneholder dem - Google Patents
Aminoindazolderivatrer aktive som kinaseinhibitorer, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som inneholder demInfo
- Publication number
- NO20041086L NO20041086L NO20041086A NO20041086A NO20041086L NO 20041086 L NO20041086 L NO 20041086L NO 20041086 A NO20041086 A NO 20041086A NO 20041086 A NO20041086 A NO 20041086A NO 20041086 L NO20041086 L NO 20041086L
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical compositions
- processes
- preparation
- compositions containing
- kinase inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Transplantation (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Tires In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Photolithography (AREA)
- Plural Heterocyclic Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96216201A | 2001-09-26 | 2001-09-26 | |
PCT/EP2002/010534 WO2003028720A1 (fr) | 2001-09-26 | 2002-09-19 | Derives d'aminoindazole agissant comme inhibiteurs de la kinase, procede de production et compositions pharmaceutiques les contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20041086L true NO20041086L (no) | 2004-03-15 |
Family
ID=25505498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20041086A NO20041086L (no) | 2001-09-26 | 2004-03-15 | Aminoindazolderivatrer aktive som kinaseinhibitorer, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som inneholder dem |
Country Status (19)
Country | Link |
---|---|
US (1) | US7511136B2 (fr) |
EP (2) | EP1820503B1 (fr) |
JP (1) | JP4542338B2 (fr) |
KR (1) | KR20040047869A (fr) |
CN (1) | CN1556702A (fr) |
AT (1) | ATE495741T1 (fr) |
BR (1) | BR0212841A (fr) |
CA (1) | CA2460145C (fr) |
CZ (1) | CZ2004359A3 (fr) |
DE (1) | DE60238999D1 (fr) |
EA (1) | EA007430B1 (fr) |
ES (2) | ES2380054T3 (fr) |
IL (1) | IL160744A0 (fr) |
MX (1) | MXPA04001114A (fr) |
NO (1) | NO20041086L (fr) |
NZ (1) | NZ531765A (fr) |
PL (1) | PL368347A1 (fr) |
WO (1) | WO2003028720A1 (fr) |
ZA (1) | ZA200401848B (fr) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2339624C2 (ru) | 2002-12-12 | 2008-11-27 | Авентис Фарма С.А. | Производные аминоиндазолов и их применение в качестве ингибиторов киназ |
FR2848554A1 (fr) * | 2002-12-12 | 2004-06-18 | Aventis Pharma Sa | Nouveaux derives d'aminoindazoles a titre de medicaments et compositions pharmaceutiques les renfermant |
UA81790C2 (uk) | 2002-12-19 | 2008-02-11 | Фармация Италия С.П.А. | Заміщені піролопіразольні похідні як інгібітори кінази |
US7135575B2 (en) * | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
GEP20094664B (en) | 2003-05-22 | 2009-04-10 | Nerviano Medical Sciences Srl | Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
US7141568B2 (en) | 2003-07-09 | 2006-11-28 | Pfizer Italia S.R.L. | Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
EP1791831A4 (fr) * | 2003-11-19 | 2009-07-08 | Signal Pharm Llc | Procedes de traitement de maladies et de troubles par le ciblage de kinases multiples |
TW200526204A (en) | 2004-02-03 | 2005-08-16 | Pharmacia Italia Spa | 1h-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors |
JP4734119B2 (ja) * | 2004-02-12 | 2011-07-27 | 田辺三菱製薬株式会社 | インダゾール化合物及びその医薬用途 |
KR20060114022A (ko) * | 2004-02-27 | 2006-11-03 | 에프. 호프만-라 로슈 아게 | 인다졸 유도체 및 그들을 함유하는 약학 조성물 |
EP1647549A1 (fr) | 2004-10-14 | 2006-04-19 | Laboratoire Theramex | Indazoles, benzisoxazoles et benzisothiazoles en tant qu'agents oestrogéniques |
DE602005023333D1 (de) | 2004-10-15 | 2010-10-14 | Takeda Pharmaceutical | Kinaseinhibitoren |
JP5303271B2 (ja) | 2005-07-19 | 2013-10-02 | ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ | キナーゼ阻害剤として有用な1H−チエノ[2,3−c]ピラゾール化合物 |
BRPI0614884A2 (pt) * | 2005-08-25 | 2011-04-19 | Hoffmann La Roche | inibidores de p38 map cinase e métodos para uso dos mesmos |
US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
US7618982B2 (en) | 2005-12-19 | 2009-11-17 | Nerviano Medical Sciences S.R.L. | Heteroarylpyrrolopyridinones active as kinase inhibitors |
UA94733C2 (ru) * | 2006-01-31 | 2011-06-10 | Эррей Биофарма Инк. | Ингибиторы киназы и способы их использования |
US9012487B2 (en) | 2006-03-03 | 2015-04-21 | Nerviano Medical Sciences S.R.L. | Bicyclo-pyrazoles active as kinase inhibitors |
EP2036894A4 (fr) * | 2006-06-30 | 2011-01-12 | Kyowa Hakko Kirin Co Ltd | Inhibiteur d'aurora |
DE102006030479A1 (de) * | 2006-07-01 | 2008-03-20 | Merck Patent Gmbh | Indazolderivate |
GEP20135728B (en) | 2006-10-09 | 2013-01-25 | Takeda Pharmaceuticals Co | Kinase inhibitors |
CA2672494A1 (fr) | 2006-12-14 | 2008-06-19 | Nps Pharmaceuticals, Inc. | Utilisation de derives de la d-serine pour le traitement de troubles de l'anxiete |
US20080146549A1 (en) * | 2006-12-18 | 2008-06-19 | Coleman Peter R | Accelerated opiate dependence detoxification process |
WO2008074676A1 (fr) * | 2006-12-19 | 2008-06-26 | F. Hoffmann-La Roche Ag | Inhibiteurs de la pyrazolo [3,4-d] pyrimidine p38 map kinase |
PL2120932T3 (pl) * | 2006-12-20 | 2015-02-27 | Nerviano Medical Sciences Srl | Indazolowe pochodne jako inhibitory kinazy do leczenia raka |
JP5337717B2 (ja) | 2007-02-27 | 2013-11-06 | ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ | キナーゼ阻害剤として活性なイソキノリノピロロピリジノン |
EP2003129B1 (fr) | 2007-06-11 | 2017-08-09 | Nerviano Medical Sciences S.r.l. | Dérivés de 1H-pyrido[3,4-B]indol-1-one et de 2,3,4,9-tétrahydro-1H-bêta-carbolin-1-one |
WO2008156757A1 (fr) * | 2007-06-19 | 2008-12-24 | Takeda Pharmaceutical Company Limited | Composés d'indazole permettant d'activer la glucokinase |
KR101653548B1 (ko) * | 2008-01-08 | 2016-09-02 | 머크 샤프 앤드 돔 리미티드 | 2-{4-[(3s)-피페리딘-3-일]페닐}-2h-인다졸-7-카복스아미드의 약제학적으로 허용되는 염 |
ES2415907T3 (es) | 2008-07-24 | 2013-07-29 | Nerviano Medical Sciences S.R.L. | Combinación terapéutica que comprende un inhibidor de cinasas aurora y agentes antiproliferativos |
US8354399B2 (en) * | 2008-12-18 | 2013-01-15 | Nerviano Medical Sciences S.R.L. | Substituted indazole derivatives active as kinase inhibitors |
KR101913441B1 (ko) | 2010-12-17 | 2018-10-30 | 네르비아노 메디칼 사이언시스 에스.알.엘. | 키나제 억제제로서 치환된 피라졸로-퀴나졸린 유도체 |
WO2012152763A1 (fr) | 2011-05-12 | 2012-11-15 | Nerviano Medical Sciences S.R.L. | Dérivés d'indazole substitués actifs en tant qu'inhibiteurs de kinases |
WO2015143652A1 (fr) * | 2014-03-26 | 2015-10-01 | Merck Sharp & Dohme Corp. | Inhibiteurs de la kinase trka, compositions et méthodes associées |
EP3307725A1 (fr) | 2015-06-11 | 2018-04-18 | Basilea Pharmaceutica International AG | Inhibiteurs de la pompe à efflux et utilisations thérapeutiques correspondantes |
DE102015012050A1 (de) * | 2015-09-15 | 2017-03-16 | Merck Patent Gmbh | Verbindungen als ASIC-Inhibitoren und deren Verwendungen |
TW202014408A (zh) | 2018-07-03 | 2020-04-16 | 美商Ifm Due有限公司 | 用於治療與sting活性相關之病症的化合物及組合物 |
WO2021067801A1 (fr) * | 2019-10-03 | 2021-04-08 | Ifm Due, Inc. | Composés et compositions pour traiter des états pathologiques associés à une activité de sting |
KR20240056718A (ko) * | 2021-08-10 | 2024-04-30 | 아이에프엠 듀, 인크. | Sting 활성과 연합된 상태를 치료하기 위한 화합물 및 조성물 |
WO2023137041A1 (fr) * | 2022-01-12 | 2023-07-20 | Ifm Due, Inc. | Composés et compositions pour le traitement d'états associés à l'activité de sting |
WO2023137034A1 (fr) * | 2022-01-12 | 2023-07-20 | Ifm Due, Inc. | Composés et compositions pour le traitement d'états associés à l'activité de sting |
WO2023186773A1 (fr) | 2022-03-30 | 2023-10-05 | Nerviano Medical Sciences S.R.L. | Dérivés de 3-amino indazole substitués utilisés en tant qu'inhibiteurs de kinase |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US474964A (en) * | 1892-05-17 | Electrically-heated matrix-press | ||
US28939A (en) | 1860-06-26 | Improvement in stills | ||
US2478048A (en) * | 1943-01-23 | 1949-08-02 | Winthrop Stearns Inc | Sulfanilamidoindazoles and method of production |
BE626284A (fr) | 1962-04-28 | |||
US3755332A (en) * | 1971-07-01 | 1973-08-28 | Ciba Geigy Corp | Substituted 4 indazolaminoquinolines |
DE2458965C3 (de) | 1974-12-13 | 1979-10-11 | Bayer Ag, 5090 Leverkusen | 3-Amino-indazol-N-carbonsäure-Derivate, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel |
JPS51143010A (en) * | 1975-06-04 | 1976-12-09 | Kao Corp | Stable bleaching detergent composition |
DE2653005A1 (de) * | 1975-12-03 | 1977-06-08 | Sandoz Ag | Neue organische verbindungen, ihre verwendung und herstellung |
JPS5754175A (ja) * | 1980-09-19 | 1982-03-31 | Asahi Chem Ind Co Ltd | Shinkina33aminoindazoorujudotai |
DE3166987D1 (en) * | 1980-09-18 | 1984-12-06 | Asahi Chemical Ind | 3-aminoindazole derivatives and process for preparation thereof |
DE3381617D1 (de) * | 1982-03-17 | 1990-07-05 | Asahi Chemical Ind | Indazol-derivate. |
JPS6061569A (ja) | 1983-09-16 | 1985-04-09 | Asahi Chem Ind Co Ltd | 新規な3位置換アミン誘導体 |
JPS60172969A (ja) * | 1984-02-16 | 1985-09-06 | Asahi Chem Ind Co Ltd | インダゾ−ル誘導体の製造法 |
JP2567621B2 (ja) | 1986-08-22 | 1996-12-25 | 塩野義製薬株式会社 | フエノ−ル類またはフエニルアミン類のオルトシアノ化法 |
US4864032A (en) | 1987-07-02 | 1989-09-05 | Ortho Pharmaceutical Corporation | Process for the preparation of indazoles |
FR2661669B1 (fr) | 1990-05-04 | 1992-08-14 | Francais Ciments | Adjuvant pour produits du beton. |
JP3148960B2 (ja) * | 1993-04-12 | 2001-03-26 | コニカ株式会社 | 写真用シアンカプラー |
JP3245765B2 (ja) * | 1994-07-05 | 2002-01-15 | コニカ株式会社 | 写真用シアンカプラー |
CZ378497A3 (cs) * | 1995-06-02 | 1998-04-15 | Synthelabo | Deriváty oxazolidinonu, způsob jejich přípravy a jejich terapeutické použití |
DE19534649A1 (de) | 1995-09-19 | 1997-03-20 | Hoechst Ag | 2-Cyano-3-mercaptocrotonsäureamide |
JP4403482B2 (ja) | 1997-12-22 | 2010-01-27 | バイエル コーポレイション | 置換複素環尿素合成のための中間体およびその製造方法 |
PT1073435E (pt) * | 1998-04-30 | 2004-10-29 | Abbott Gmbh & Co Kg | Derivados triciclicos substituidos de pirazole com actividade de proteina-quinase |
YU54202A (sh) * | 2000-01-18 | 2006-01-16 | Agouron Pharmaceuticals Inc. | Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije |
US7217722B2 (en) * | 2000-02-01 | 2007-05-15 | Kirin Beer Kabushiki Kaisha | Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
CA2422367C (fr) | 2000-09-15 | 2010-05-18 | Vertex Pharmaceuticals Incorporated | Composes de pyrazole pouvant etre utilises comme inhibiteurs de la proteine kinase |
KR100947185B1 (ko) | 2000-12-21 | 2010-03-15 | 버텍스 파마슈티칼스 인코포레이티드 | 단백질 키나제 억제제로서 유용한 피라졸 화합물 및 이를 포함하는 조성물 |
US7135288B2 (en) * | 2002-09-27 | 2006-11-14 | Ut-Battelle, Llc | Combinatorial synthesis of ceramic materials |
-
2002
- 2002-09-19 EA EA200400476A patent/EA007430B1/ru unknown
- 2002-09-19 IL IL16074402A patent/IL160744A0/xx unknown
- 2002-09-19 BR BR0212841-1A patent/BR0212841A/pt not_active IP Right Cessation
- 2002-09-19 US US10/490,189 patent/US7511136B2/en not_active Expired - Lifetime
- 2002-09-19 EP EP07107760A patent/EP1820503B1/fr not_active Expired - Lifetime
- 2002-09-19 WO PCT/EP2002/010534 patent/WO2003028720A1/fr active Application Filing
- 2002-09-19 CZ CZ2004359A patent/CZ2004359A3/cs unknown
- 2002-09-19 DE DE60238999T patent/DE60238999D1/de not_active Expired - Lifetime
- 2002-09-19 NZ NZ531765A patent/NZ531765A/en unknown
- 2002-09-19 EP EP02774629A patent/EP1432416B1/fr not_active Expired - Lifetime
- 2002-09-19 CN CNA028185986A patent/CN1556702A/zh active Pending
- 2002-09-19 CA CA2460145A patent/CA2460145C/fr not_active Expired - Lifetime
- 2002-09-19 KR KR10-2004-7004532A patent/KR20040047869A/ko not_active Application Discontinuation
- 2002-09-19 AT AT02774629T patent/ATE495741T1/de not_active IP Right Cessation
- 2002-09-19 MX MXPA04001114A patent/MXPA04001114A/es not_active Application Discontinuation
- 2002-09-19 JP JP2003532052A patent/JP4542338B2/ja not_active Expired - Lifetime
- 2002-09-19 ES ES07107760T patent/ES2380054T3/es not_active Expired - Lifetime
- 2002-09-19 ES ES02774629T patent/ES2357502T3/es not_active Expired - Lifetime
- 2002-09-19 PL PL02368347A patent/PL368347A1/xx not_active Application Discontinuation
-
2004
- 2004-03-05 ZA ZA200401848A patent/ZA200401848B/xx unknown
- 2004-03-15 NO NO20041086A patent/NO20041086L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1432416A1 (fr) | 2004-06-30 |
CA2460145A1 (fr) | 2003-04-10 |
ATE495741T1 (de) | 2011-02-15 |
CN1556702A (zh) | 2004-12-22 |
EP1820503A3 (fr) | 2008-05-21 |
EP1820503A2 (fr) | 2007-08-22 |
KR20040047869A (ko) | 2004-06-05 |
CZ2004359A3 (cs) | 2004-09-15 |
EA007430B1 (ru) | 2006-10-27 |
US7511136B2 (en) | 2009-03-31 |
CA2460145C (fr) | 2011-04-26 |
EP1820503B1 (fr) | 2012-02-22 |
WO2003028720A1 (fr) | 2003-04-10 |
ES2357502T3 (es) | 2011-04-27 |
MXPA04001114A (es) | 2004-05-20 |
JP2005512967A (ja) | 2005-05-12 |
EP1432416B1 (fr) | 2011-01-19 |
DE60238999D1 (de) | 2011-03-03 |
NZ531765A (en) | 2006-02-24 |
BR0212841A (pt) | 2004-08-03 |
IL160744A0 (en) | 2004-08-31 |
ES2380054T3 (es) | 2012-05-08 |
JP4542338B2 (ja) | 2010-09-15 |
US20040254177A1 (en) | 2004-12-16 |
ZA200401848B (en) | 2005-03-07 |
PL368347A1 (en) | 2005-03-21 |
EA200400476A1 (ru) | 2004-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20041086L (no) | Aminoindazolderivatrer aktive som kinaseinhibitorer, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som inneholder dem | |
NO20040547L (no) | Amino-ftalazinonderivater aktive som kinaseinhibitorer, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende disse. | |
MXPA04000920A (es) | Derivados de aminoisoxazol activos como inhibidores de la cinasa. | |
MXPA02012164A (es) | Derivados de tiofeno activos como inhibidores de cinasa, proceso para su preparacion y composiciones farmaceuticas que los comprenden. | |
CA2486101A1 (fr) | Derives d'aminoindazole agissant comme inhibiteurs de kinase, methode d'obtention et compositions pharmaceutiques les renfermant | |
GB0102687D0 (en) | Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them | |
WO2003070236A3 (fr) | Derives de pyrazole tricyclique, procedes de leur preparation et leur utilisation en tant qu'agents anti-tumoraux | |
MXPA05009719A (es) | Derivados de biciclo-pirazol activos como inhibidores de cinasa, procedimiento para su preparacion y composiciones farmaceuticas que los comprenden. | |
GB0330043D0 (en) | Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them | |
GB0330042D0 (en) | Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions them | |
DE602004017194D1 (de) | Pyridylpyrrol-derivate als wirksame kinase-hemmer | |
NO20030381L (no) | Bicyklopyrazoler som er aktive som kinaseinhibitorer, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder slikeforbindelser | |
MXPA06000302A (es) | Derivados de pirazolil-indol activos como inhibidores de cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden. | |
BR0314797A (pt) | Derivados da pirimidineamida e o uso dos mesmos | |
BRPI0413438A (pt) | derivados de pirimidilpirrol ativos como inibidores de cinase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |